$ cat ./records/gates-foundation-sponsors-formation-of-global-cattle-tick-vaccine-2015.txt
Gates Foundation Sponsors Formation of Global Cattle Tick Vaccine Consortium CATVAC
[RECORD.TXT] · cat --full
The Bill & Melinda Gates Foundation sponsored a two-day international scientific meeting in Mohammedia, Morocco, which resulted in the formation of the Cattle Tick Vaccine Consortium (CATVAC). The meeting convened leading tick vaccine researchers to share antigen data, select the most promising antigen combinations for a commercial vaccine against Rhipicephalus microplus — the invasive cattle blue tick — and establish a formal collaboration. R. microplus costs billions annually through blood loss, hide damage, and transmission of babesiosis and anaplasmosis. The consortium's formation and scientific rationale were published in the peer-reviewed journal Parasites & Vectors in 2016.
Free forever · No ads · Solo developer
If this was worth a read, help make the next entry possible.
Every entry in this archive was researched, verified, and written by one person — for free. No corporate funding. No ad revenue. Just a developer who believes verified history should be accessible to everyone. Your donation directly funds new entries.
Crypto accepted · No subscription required
← Previous
Gates Foundation Backs GALVmed Anaplasmosis Vaccine Research for Sub-Saharan African Cattle Herds
Next →
Delivers TED Talk 'The Next Outbreak? We're Not Ready' Warning of Pandemic Risk
[CROSS_REFERENCES] · grep --category='Global Health'
Related Accomplishments
January 2026
Gates-backed World Mosquito Program reaches 16 million people protected from dengue via Wolbachia method
The World Mosquito Program — backed in part by the Gates Foundation — announced in January 2026 that its Wolbachia-infected mosquito releases had reached over 16.1 million people across multiple countries, including Colombia, Indonesia, Brazil, Sri Lanka, Fiji, Vanuatu, and Vietnam. Wolbachia-carrying Aedes aegypti mosquitoes — which block dengue, Zika, chikungunya, and yellow fever transmission — had established self-sustaining populations in treated cities without requiring ongoing releases. Gold-standard randomised trials in Indonesia showed a 77% reduction in dengue incidence. The program represented one of the largest and most cost-effective vector control deployments in history.
2025
Gates-Funded Monoclonal Antibody Shows Early Promise as a Single-Shot Malaria Shield
[ARCHIVE_FUNDING] · INDEPENDENT · NO ADS
One developer. >300 verified entries. Zero ads. Forever free.
No sponsors, no paywall, no algorithm. If this archive has been useful to you, reader support is what keeps it running.